Literature DB >> 28456622

Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells.

Balaji Banoth1, Suzanne L Cassel2.   

Abstract

Keywords:  Bruton tyrosine kinase; Nucleotide-binding leucine-rich repeat receptor family pyrin domain containing protein 3; ibrutinib

Mesh：

Substances：

Year:  2017        PMID： 28456622     DOI： 10.1016/j.jaci.2017.03.041

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

1.  [Bruton tyrosine kinase inhibition in dermatology and allergology].

Authors:  B Wedi
Journal:  Hautarzt       Date:  2018-06       Impact factor: 0.751

Review 2.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

Review 3.  Targeting the NLRP3 Inflammasome via BTK.

Authors:  Alexander N R Weber
Journal:  Front Cell Dev Biol       Date:  2021-02-25

4.  BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.

Authors:  Zsófia Agnes Bittner; Xiao Liu; Maria Mateo Tortola; Ana Tapia-Abellán; Sangeetha Shankar; Liudmila Andreeva; Matthew Mangan; Marianne Spalinger; Hubert Kalbacher; Peter Düwell; Marta Lovotti; Karlotta Bosch; Sabine Dickhöfer; Ana Marcu; Stefan Stevanović; Franziska Herster; Yamel Cardona Gloria; Tzu-Hsuan Chang; Francesca Bork; Carsten L Greve; Markus W Löffler; Olaf-Oliver Wolz; Nadine A Schilling; Jasmin B Kümmerle-Deschner; Samuel Wagner; Anita Delor; Bodo Grimbacher; Oliver Hantschel; Michael Scharl; Hao Wu; Eicke Latz; Alexander N R Weber
Journal:  J Exp Med       Date:  2021-09-23       Impact factor: 14.307

5.  Inhibition of Bruton's Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization.

Authors:  Min Yu; Xuecheng Wu; Liyao Peng; Mingxia Yang; Hong Zhou; Jian Xu; Jingjing Wang; Hong Wang; Weiping Xie; Hui Kong
Journal:  Oxid Med Cell Longev       Date:  2022-08-29       Impact factor: 7.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.